Botulinum toxin for conditions of the female pelvis

[1]  S. Kenyon,et al.  Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). , 2012, European urology.

[2]  J. Krhut,et al.  Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study , 2012, Spinal Cord.

[3]  I. Cullen,et al.  Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity. , 2012, European urology.

[4]  P. Dasgupta,et al.  Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates. , 2012, European urology.

[5]  F. Kamani,et al.  Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial , 2012, Langenbeck's Archives of Surgery.

[6]  C. Harmston,et al.  Excellent response rate of anismus to botulinum toxin if rectal prolapse misdiagnosed as anismus (‘pseudoanismus’) is excluded , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[7]  E. Rovner.  Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder , 2012 .

[8]  G. Herbison,et al.  Botulinum toxin injections for adults with overactive bladder syndrome. , 2011, The Cochrane database of systematic reviews.

[9]  M. Brin,et al.  Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. , 2011, European urology.

[10]  P. Dasgupta,et al.  Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). , 2011, European urology.

[11]  H. Kuo.  Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics , 2011, Neurourology and urodynamics.

[12]  J. Warusavitarne,et al.  Long‐term outcome of the use of botulinum toxin injection for functional anal pain , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[13]  Ursula Wesselmann,et al.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. , 2011, The Journal of urology.

[14]  L. Burrows,et al.  Intralevator injection of botulinum toxin for the treatment of hypertonic pelvic floor muscle dysfunction and vestibulodynia. , 2011, The journal of sexual medicine.

[15]  J. Andrews.  Vulvodynia Interventions—Systematic Review and Evidence Grading , 2011, Obstetrical & gynecological survey.

[16]  P. Dasgupta,et al.  Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo‐controlled dose‐finding study in idiopathic overactive bladder , 2011, Neurourology and urodynamics.

[17]  Kenneth J. Smith,et al.  InterStim Sacral Neuromodulation and Botox Botulinum-A Toxin Intradetrusor Injections for Refractory Urge Urinary Incontinence: A Decision Analysis Comparing Outcomes Including Efficacy and Complications , 2010, Female pelvic medicine & reconstructive surgery.

[18]  E. Yiannakopoulou.  Botulinum toxin and anal fissure: Efficacy and safety systematic review , 2011, International Journal of Colorectal Disease.

[19]  R. Dmochowski,et al.  Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. , 2010, The Journal of urology.

[20]  T. Abdel-Meguid.  Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial. , 2010, The Journal of urology.

[21]  A. Rao,et al.  The Unusual History and the Urological Applications of Botulinum Neurotoxin , 2010, Urologia Internationalis.

[22]  M. Youssef,et al.  Comparative Study between Surgical and Non-surgical Treatment of Anismus in Patients with Symptoms of Obstructed Defecation: A Prospective Randomized Study , 2010, Journal of Gastrointestinal Surgery.

[23]  P. Latthe,et al.  Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review , 2010, International Urogynecology Journal.

[24]  S. de Wachter,et al.  Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review , 2010, Urologia Internationalis.

[25]  Jennifer M Wu,et al.  Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. , 2009, The Journal of urology.

[26]  L. Bertolasi,et al.  Botulinum Neurotoxin Type A Injections for Vaginismus Secondary to Vulvar Vestibulitis Syndrome , 2009, Obstetrics and gynecology.

[27]  L. Lundvall,et al.  Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. , 2009, The journal of sexual medicine.

[28]  M. Chancellor,et al.  Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome , 2009, BJU international.

[29]  J. Abbott,et al.  Using botulinum toxin for pelvic indications in women , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[30]  A. Brashear.  Clinical Comparisons of Botulinum Neurotoxin Formulations , 2008, The neurologist.

[31]  W. Khafagy,et al.  Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients , 2008, International Journal of Colorectal Disease.

[32]  H. Kuo.  Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. , 2007, The Journal of urology.

[33]  F. Cadeddu,et al.  Randomized clinical trial comparing botulinum toxin injections with 0·2 per cent nitroglycerin ointment for chronic anal fissure , 2007, The British journal of surgery.

[34]  D. Dressler,et al.  Pharmacology of therapeutic botulinum toxin preparations , 2007, Disability and rehabilitation.

[35]  H. Haefner.  Report of the International Society for the Study of Vulvovaginal Disease Terminology and Classification of Vulvodynia , 2007, Journal of lower genital tract disease.

[36]  F. Cadeddu,et al.  Experience with Type A Botulinum Toxin for Treatment of Outlet-Type Constipation , 2006, The American Journal of Gastroenterology.

[37]  J. Abbott,et al.  Botulinum Toxin Type A for Chronic Pain and Pelvic Floor Spasm in Women: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.

[38]  P. Gallien,et al.  Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  F. Sierra.  Evidence-Based Medicine (EBM) in Practice: Applying Number Needed to Treat and Number Needed to Harm , 2005, The American Journal of Gastroenterology.

[40]  J. Kempf,et al.  Dyssynergic Defecation: Demographics, Symptoms, Stool Patterns, and Quality of Life , 2004, Journal of clinical gastroenterology.

[41]  A. Bentivoglio,et al.  Botulinum neurotoxin to treat chronic anal fissure: results of a randomized ‘Botox vs. Dysport’ controlled trial , 2004, Alimentary pharmacology & therapeutics.

[42]  J. Dipalma.  Current treatment options for chronic constipation. , 2004, Reviews in gastroenterological disorders.

[43]  S. Leventoğlu,et al.  Comparison of Botulinum Toxin Injection and Lateral Internal Sphincterotomy for the Treatment of Chronic Anal Fissure , 2003, Diseases of the colon and rectum.

[44]  Z. Halpern,et al.  Botulinum toxin type-a in therapy of patients with anismus , 2001, Diseases of the colon and rectum.

[45]  B. Skjoldbye,et al.  Chronic idiopathic anal pain , 2001, Diseases of the colon and rectum.

[46]  A. Bentivoglio,et al.  Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome , 2000, Diseases of the colon and rectum.

[47]  A. Bentivoglio,et al.  Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. , 2000, American journal of surgery.

[48]  D. Nyam,et al.  Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence , 1999, Diseases of the colon and rectum.

[49]  A. Shafik,et al.  Botulin Toxin in the Treatment of Nonrelaxing Puborectalis Syndrome , 1998, Digestive Surgery.

[50]  V. A. Parikh.  The use of botulinum toxin for anal fissure. , 1997, Journal of the Royal College of Surgeons of Edinburgh.

[51]  J. Nogueras,et al.  Initial North American experience with botulinum toxin type a for treatment of anismus , 1996, Diseases of the colon and rectum.

[52]  S. Wexner,et al.  Patterns of anismus and the relation to biofeedback therapy , 1996, Diseases of the colon and rectum.

[53]  W. Jost,et al.  Use of botulinum toxin in anal fissure , 1993, Diseases of the colon and rectum.

[54]  L. Melton,et al.  Functional constipation and outlet delay: a population-based study. , 1993, Gastroenterology.

[55]  N. Williams,et al.  TREATMENT OF ANISMUS IN INTRACTABLE CONSTIPATION WITH BOTULINUM A TOXIN , 1988, The Lancet.

[56]  D. M. Preston,et al.  Anismus in chronic constipation , 1985, Digestive diseases and sciences.